Join us in-person &/or On-Demand for our 2026 Cancer Conference Series, uniquely designed to bring together leaders in cancer research & treatment to collaboratively examine the disease from all angles & redefine the future of cancer medicine.
While immunotherapies have transformed cancer treatment, they only benefit from a subset of patients, with many failing to respond or quickly developing resistance. This Keystone Symposia will examine the limitations of immunotherapies, the reasons for failure and mechanisms of resistance, to guide strategies to overcome these hurdles and improve clinical outcomes.
Sessions will highlight emerging research on targeting stromal and myeloid cells, tumor recognition by lymphoid lineages, and advanced technologies like spatial imaging and AI to understand the tumor microenvironment. By convening leading experts across academia, industry and clinical medicine to review the successes and failures of existing therapies, explore new host immune targets, and discuss the challenges and potential of combination therapies, the meeting aims to inspire collaboration and accelerate development of more effective cancer immunotherapies.
